90713 Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use

Name of the Procedure:

Poliovirus Vaccine, Inactivated (IPV)
Common Name: IPV Immunization
Technical Term: Inactivated Poliovirus Vaccine

Summary

The inactivated poliovirus vaccine (IPV) is an injectable immunization used to protect individuals from poliomyelitis, commonly known as polio. This vaccine can be administered either subcutaneously (under the skin) or intramuscularly (into the muscle).

Purpose

IPV is designed to prevent poliovirus infections that can cause paralysis and other severe complications. The goal is to immunize individuals against the three types of poliovirus, thereby reducing the incidence of polio and contributing to global eradication efforts.

Indications

• Routine immunization for children as part of the recommended vaccination schedule.
• Immunization of adults who have not been previously vaccinated.
• Booster doses for travelers to regions where polio is still endemic or where outbreaks are occurring.

Preparation

• No specific preparation such as fasting is required.
• Ensure the patient’s immunization history is up-to-date.
• Inform the healthcare provider of any allergies, especially to antibiotics like streptomycin, neomycin, or polymyxin B.

Procedure Description

1. The healthcare provider will clean the injection site with an antiseptic wipe.
2. Depending on the chosen method, the vaccine is administered either subcutaneously in the upper arm or thigh or intramuscularly in the thigh or upper arm muscle.
3. The provider then gently injects the inactivated poliovirus vaccine.
4. After the injection, the site is covered with a sterile bandage.

No anesthesia or sedation is required for this procedure.

Duration

The injection itself only takes a few minutes, but the entire appointment may last about 15-30 minutes, including preparation and post-injection observation.

Setting

The procedure is typically performed in outpatient clinics, pediatricians’ offices, family clinics, or public health facilities.

Personnel

The vaccine is administered by a trained healthcare professional, such as a nurse or a doctor.

Risks and Complications

• Common risks include mild pain, redness, or swelling at the injection site.
• Rare risks might include severe allergic reactions (anaphylaxis).
• Other possible reactions include low-grade fever, irritability, or fatigue.

Benefits

The main benefit of IPV is robust protection against poliovirus, preventing the debilitating disease of polio. Immunity typically develops after a series of doses, providing long-term protection.

Recovery

• Post-injection care involves monitoring the injection site for any signs of adverse reactions.
• Normal activities can usually be resumed immediately.
• Follow any specific instructions provided by the healthcare provider, including dates for subsequent doses if required.

Alternatives

• Oral Poliovirus Vaccine (OPV), though less commonly used in many countries due to the rare risk of vaccine-derived poliovirus (VDPV).
• Comparing with IPV, OPV is easier to administer but has different risk profiles.

Patient Experience

During the injection, the patient may feel a brief sting or pinch at the injection site. The discomfort usually subsides quickly. Post-procedure, any mild side effects should resolve within a few days. Pain management can include over-the-counter pain relievers if necessary, as recommended by the healthcare provider.